Highest intensity level of any proton therapy system in the world
27.1% using at least one CT scanner that is 10 years old or more
Unpacking the latest moves from the U.S.Copyright Office and Librarian of Congress
Will test approach on Mevion's S250i Proton Therapy System with HYPERSCAN
Black patients experience highest death rates, shortest survival rates from cancer
Has dual channel diameters of 3.7 mm and 3.2 mm
Distributed over 50,000 masks before discovering they were fake
SBRT targets tumors directly, spares healthy tissue
May determine degree of malignancy without need for biopsies
Largest healthcare system in Chicago area in size
Philip Jacobus launched DOTmed.com in 1998. He has been involved in health care since 1977, when he visited China to sell equipment. He has done business in over 35 countries and still travels extensively. Phil is active in charity, helps rural clinics and always tries to help DOTmed users when he can.
Phil is a member of AHRA, AAMI, HFMA and the Cryogenic Society of America. He has contributed to a number of magazines and journals and has addressed trade groups.
Phil's proudest achievement is that he has been happily married to his wife Barbara since 1989, who helped him found DOTmed in 1998.
Insights from Elke Rehbock, partner at Dentons US LLP and co-chair for the manufacturing sector
Insight from Sheila Talton, president and CEO of Gray Matter Analytics
Insighta from Frederic Genin, president of IBA Proton Therapy North America
Insights from Rich Fabian, president and COO of FUJIFILM SonoSite, Inc.
Q&A with Helen Macfie, chief transformation officer at MemorialCare
Q&A with ASTRO president Dr. Laura Dawson
Insights from Dr. Charley Taylor, co-founder and chief technology officer at HeartFlow Inc.
Switching the narrative from 'artificial intelligence' to 'decision intelligence' is critical for directing healthcare’s digital transformation, writes Dr. Moira Schieke, founder and CEO of Cubismi
Insights from Dr. Maninder Bedi, founder and chief medical officer of Optimize EP
Insights from Michael Gorton, MS, JD, CEO and founder of Recuro Health, and founding CEO and chairman of Teladoc